Projects per year
Organization profile
Organisation profile
HEIM is part of the Oncology Research Center and consists of a fundamental research team located at the Faculty of the Brussels Health Campus and a translational research team located at the University Hospital. Fundamental Research consists of cancer research in different tumor models including Multiple Myeloma, Acute Myeloid Leukemia and B-cell lymphoma. The aim of this research is to find novel therapeutic targets within the field of epigenetics, tumor cross-talk and immune therapy. Translational Research covers different domains within Hematology, such as Cancer Biology, Stem Cell Therapy, Thrombophilia and HLA typing.
Fingerprint
Dive into the research topics where Hematology is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Profiles
-
Marleen Bakkus
- UZBrussel
- Vrije Universiteit Brussel
- Clinical Biology - UZB Researcher
- Hematology
Person: Researcher
-
Veerle Beckers
- UZBrussel
- Vrije Universiteit Brussel
- Hematology
- Hematology - UZB Physician
Person: Researcher, Physician
-
Ann De Becker
- UZBrussel
- Vrije Universiteit Brussel
- Hematology
- Faculty of Medicine and Pharmacy
- Hematology - UZB Physician
Person: Researcher, PhD, Physician
-
Nathan De Beule
- UZBrussel
- Vrije Universiteit Brussel
- Clinical sciences - Academic
- Hematology - UZB Physician
- Hematology
Person: Researcher, Physician
-
Wouter De Brouwer
- UZBrussel
- Vrije Universiteit Brussel
- Hematology
- Basic (bio-) Medical Sciences - Academic
- Hematology - UZB Physician
- Faculty of Medicine and Pharmacy
Person: Researcher, Physician, PhD, Advanced Master's Programme
-
OZR3740: Bilateral cooperation within the framework of a joint doctoral project: benchfee for joint PhD VUB - KU Leuven, DE COSTER Michiel
22/10/20 → 21/10/24
Project: Fundamental
-
FWOTM1002: Development of innovative NANObody-based therapies to eradicate REsidual disease in Multiple Myeloma (acronym: NANOREMM)
1/10/20 → 30/09/23
Project: Fundamental
-
FWOTM900: Modulating epigenetic mechanisms to enhance cancer immunotherapy.
Breckpot, K., De Beck, L. & Maes, K.
1/10/18 → 30/09/22
Project: Fundamental
-
OZR3286: Bilateral cooperation within the framework of a joint doctoral project: Bench Fee for Joint PhD VUB-UGent, Vlummens Philip
13/02/18 → 31/12/22
Project: Fundamental
Research output
-
18th International Myeloma Workshop 2021
Kint, N., De Brouwer, W. & Schots, R., 1 Mar 2022, In : Belgian Journal of Hematology. 13, 2, p. 95-99 5 p.Research output: Contribution to journal › Article
-
Addition of elotuzumab to lenalidomide and dexamethasone for patients with newly diagnosed, transplantation ineligible multiple myeloma (ELOQUENT-1): an open-label, multicentre, randomised, phase 3 trial
ELOQUENT-1 investigators, 2022, In : The Lancet. Haematology.Research output: Contribution to journal › Article
-
A rare case of chronic myeloid leukemia in blast phase with laboratory diagnostic challenges
Linskens, E., Demeester, S., Depreter, B., Jochmans, K., Kint, N. & Beckers, V., 4 Feb 2022.Research output: Unpublished contribution to conference › Poster
-
Belgian clinical guidance on anticoagulation management in hospitalised and ambulatory patients with COVID-19
Vanassche, T., Orlando, C., Vandenbosch, K., Gadisseur, A., Hermans, C., Jochmans, K., Minon, J-M., Motte, S., Peperstraete, H., Péters, P., Sprynger, M., Lancellotti, P., Dehaene, I., Emonts, P., Vandenbriele, C., Verhamme, P. & Oury, C., Apr 2022, In : Acta Clinica Belgica. 77, 2, p. 280-285 6 p.Research output: Contribution to journal › Article
Open Access7 Citations (Scopus) -
Correction to: Validation of Rapid Antimicrobial Susceptibility Testing directly from blood cultures using WASPLab®, including Colibrí™ and Radian® in-Line Carousel
Herroelen, P. H., Heestermans, R., Emmerechts, K., Vandoorslaer, K., Wybo, I., Piérard, D. & Muyldermans, A., 2022, In : European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology.Research output: Contribution to journal › Article
Open Access
Activities
-
Postgraduaat Klinische Biologie 2022
Barbara Depreter (Chair)27 Sep 2022Activity: Participating in or organising an event › Participating in or organizing a public lecture/debate
-
Scientific Institute of Public Health, Brussels (External organisation)
Barbara Depreter (Chair)2022 → …Activity: Membership › Membership of public/government advisory/policy group or panel
-
2022 Molecular Biology and Cytometry course.
Barbara Depreter (Member of programme committee)12 May 2022 → 13 May 2022Activity: Participating in or organising an event › Participation in conference
-
EHA2022 Hybrid Congress
Barbara Depreter (Participant)8 Jun 2022 → 12 Jun 2022Activity: Participating in or organising an event › Participation in conference
-
Webinar hematologische cellen de basis deel 2
Simke Demeester (Speaker)18 Feb 2022Activity: Talk or presentation › Talk or presentation at a workshop/seminar